Edgewise Therapeutics (EWTX) P/E (2021 - 2026)
Edgewise Therapeutics (EWTX) P/E from Mar 31, 2021 to Jul 21, 2026. The TTM Edgewise Therapeutics (EWTX) P/E is -23.90. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Edgewise Therapeutics (EWTX)
| Year | P/E | Change |
|---|---|---|
| 2026 | -23.90 | +56.86% |
| 2025 | -15.24 | -18.86% |
| 2024 | -18.78 | +142.25% |
| 2023 | -7.75 | -0.10% |
| 2022 | -7.76 | -55.94% |
| 2021 | -17.61 | N/A |
Comparison Edgewise Therapeutics (EWTX) P/E with competitors
Edgewise Therapeutics (EWTX) P/E is -23.90.